American Society of Hirudotherapy

Early venous congestion after DIEP flap breast reconstruction: case report of a successful management

Baccarani A, Starnoni M, Pappalardo M, Lattanzi M, Blessent CGF, De Maria F, De Santis G (2022) · Acta Biomedica · 1 patient

Case-level evidence: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

Study Profile

Design
single-patient case report of DIEP flap breast-reconstruction venous congestion 9 hours postoperatively, managed with combined surgical pedicle revision, intensive ICU heparin infusion, and 2 days of medicinal-leech therapy (Università di Modena e Reggio Emilia, Italy)
Patient
1
Presentation and intervention
Combined microsurgical pedicle revision + IV heparin infusion + medicinal leech therapy for 2 days for DIEP venous congestion
Outcome
Complete resolution of flap venous congestion; patient discharged with viable DIEP flap reconstruction; case illustrates multidisciplinary protocol with ICU-level monitoring, heparin, and leech therapy as concurrent interventions; emphasizes 6-8 hour irreversible-damage window for venous congestion recognition
Follow-up duration
Acute postoperative through discharge

Key Findings

  • Successful DIEP flap salvage with combined surgery + heparin + 2-day leech therapy
  • Authors emphasize 6-8 hour irreversible-damage window for venous congestion
  • Demonstrates multidisciplinary ICU-level care including leech application
  • Adds Italian academic-center experience to the published DIEP leech-salvage literature
  • Consistent with broader Rajaram 2024 systematic review pooled estimates

Limitations

  • Single case (n=1) — cannot generalize
  • Combined intervention prevents isolation of leech contribution
  • Limited follow-up duration
  • No standardized outcome measure
  • Single-center experience

Clinical Implications

Baccarani 2022 illustrates real-world DIEP flap salvage protocols in an Italian academic plastic surgery program. For US clinicians under K040187, the case reinforces the value of rapid recognition (<6-8 hours), multidisciplinary involvement (microsurgery + ICU + pharmacy), and combined-modality therapy (surgical pedicle revision + heparin + leech therapy) for DIEP venous congestion. Consistent with Rajaram 2024 SR pooled outcomes.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.